EZH2 and metabolic dysfunction-associated steatotic liver disease: In conclusion, our results suggest that the down-regulation of the EZH2 or a dysfunctional mutated EZH2 associated with gene polymorphisms could be correlated with the high risk of NAFLD developing in humans.